Schlossmacher
Jüergen Schlossmacher, Bergheim DE
Patent application number | Description | Published |
---|---|---|
20130345330 | METHOD FOR PRODUCING FLEXIBLE POLYURETHANE FOAMS - A process for the preparation of polyricinoleic acid esters comprising the step of reaction of ricinoleic acid with an alcohol component which comprises mono- and/or polyfunctional alcohols having a molecular weight of ≧32 g/mol to ≦40 g/mol, wherein the reaction is carried out at least partly in the presence of a catalyst. The amount of catalyst, based on the total weight of the ricinoleic acid and the alcohol component, is in a range of from ≧10 ppm to ≦100 ppm. The reaction is ended when the acid number of the reaction product obtained is ≧5 mg of KOH/g to ≦100 mg of KOH/g. The invention furthermore relates to a polyurethane polymer, in particular a flexible polyurethane foam, which is obtainable using these polyricinoleic acid esters. | 12-26-2013 |
Jürgen Schlossmacher, Bergheim DE
Patent application number | Description | Published |
---|---|---|
20110236671 | METHOD FOR PRODUCING POLYESTER POLYOLS HAVING LOW AMOUNTS OF DIOXANE WASTE - Polyester polyols are produced from at least one carboxylic acid hydride and diethylene glycol by a process in which the formation of 1,4-dioxane is suppressed. These polyester polyols are useful for producing polyurethane (PUR) and polyisocyanurate (PIR) foams and metal composite elements containing these PUR or PIR foams. | 09-29-2011 |
20120123009 | POLYESTER POLYOLS MADE OF ISOPHTHALIC ACID AND/OR TEREPHTHALIC ACID AND OLIGOALKYL OXIDES - The present invention relates to a method for producing a polyester polyol having a concentration of ether groups in the range from 9.0 mol/kg of polyester polyol to 22 mol/kg polyester polyol, characterized in that (i) in a first step (A) isophthalic acid, optionally in the form of a C | 05-17-2012 |
Michael Schlossmacher, Ottawa CA
Patent application number | Description | Published |
---|---|---|
20110038851 | TREATMENT OF SYNUCLEINOPATHIES - This invention relates generally to treating synucleinopathies in subjects that are not clinically diagnosed with a lysosomal storage disease, as well as associated methods of making medicaments and screening methods. | 02-17-2011 |
20130177549 | Treatment of Synucleinopathies - This invention relates generally to treating synucleinopathies in subjects that are not clinically diagnosed with a lysosomal storage disease, as well as associated methods of making medicaments and screening methods. | 07-11-2013 |
Michael Gebhard Schlossmacher, Ottawa CA
Patent application number | Description | Published |
---|---|---|
20110159527 | METHODS AND KITS FOR DIAGNOSING NEURODEGENERATIVE DISEASE - Methods and diagnostic kits for determining whether a subject may develop a or for diagnosing a neurodegenerative disease. The method includes quantitating the amount of alpha-synuclein and total protein in a cerebrospinal fluid (CSF) sample obtained from the subject and calculating a ratio of alpha-synuclein to total protein content; comparing the ratio of alpha-synuclein to total protein content in the CSF sample with the alpha-synuclein to total protein content ratio in CSF samples obtained from healthy neurodegenerative disease-free subjects; and (c) determining from the comparison whether the subject has a likelihood to develop neurodegenerative disease or making a diagnosis of neurodegenerative disease in a subject. A difference in the ratio of alpha-synuclein to total protein content indicates that the subject has a likelihood to develop a neurodegenerative disease or has developed a neurodegenerative disease. | 06-30-2011 |